These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28125865)

  • 41. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
    Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Halfon P; Ruiz F; Smith JS
    Int J Cancer; 2011 Aug; 129(3):691-701. PubMed ID: 20941740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.
    Smeets SJ; van der Plas M; Schaaij-Visser TB; van Veen EA; van Meerloo J; Braakhuis BJ; Steenbergen RD; Brakenhoff RH
    Int J Cancer; 2011 Apr; 128(7):1596-605. PubMed ID: 20499310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.
    Chen W; Zhang X; Molijn A; Jenkins D; Shi JF; Quint W; Schmidt JE; Wang P; Liu YL; Li LK; Shi H; Liu JH; Xie X; Niyazi M; Yang P; Wei LH; Li LY; Li J; Liu JF; Zhou Q; Hong Y; Li L; Li Q; Zhou HL; Bian ML; Chen J; Qiao YL; Smith JS
    Cancer Causes Control; 2009 Nov; 20(9):1705-13. PubMed ID: 19705288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens.
    Lesnikova I; Lidang M; Hamilton-Dutoit S; Koch J
    Diagn Pathol; 2009 Jul; 4():22. PubMed ID: 19589135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial.
    Sargent A; Bailey A; Almonte M; Turner A; Thomson C; Peto J; Desai M; Mather J; Moss S; Roberts C; Kitchener HC;
    Br J Cancer; 2008 May; 98(10):1704-9. PubMed ID: 18392052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
    de Sanjosé S; Diaz M; Castellsagué X; Clifford G; Bruni L; Muñoz N; Bosch FX
    Lancet Infect Dis; 2007 Jul; 7(7):453-9. PubMed ID: 17597569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
    Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
    Dehn D; Torkko KC; Shroyer KR
    Cancer; 2007 Feb; 111(1):1-14. PubMed ID: 17219448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
    Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
    Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular biology of human papillomavirus infection and cervical cancer.
    Doorbar J
    Clin Sci (Lond); 2006 May; 110(5):525-41. PubMed ID: 16597322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia.
    Hillemanns P; Wang X
    Gynecol Oncol; 2006 Feb; 100(2):276-82. PubMed ID: 16300821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetics of cervical cancer. An overview and therapeutic perspectives.
    Dueñas-González A; Lizano M; Candelaria M; Cetina L; Arce C; Cervera E
    Mol Cancer; 2005 Oct; 4():38. PubMed ID: 16248899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.
    Sahebali S; Depuydt CE; Boulet GA; Arbyn M; Moeneclaey LM; Vereecken AJ; Van Marck EA; Bogers JJ
    Int J Cancer; 2006 Mar; 118(5):1254-60. PubMed ID: 16161049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
    Castle PE; Solomon D; Schiffman M; Wheeler CM
    J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
    Murphy N; Ring M; Heffron CC; King B; Killalea AG; Hughes C; Martin CM; McGuinness E; Sheils O; O'Leary JJ
    J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
    Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
    BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
    Nieh S; Chen SF; Chu TY; Lai HC; Fu E
    Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium.
    Zhou XB; Guo M; Quan LP; Zhang W; Lu ZM; Wang QH; Ke Y; Xu NZ
    World J Gastroenterol; 2003 Jun; 9(6):1170-3. PubMed ID: 12800217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer.
    Milde-Langosch K; Hagen M; Bamberger AM; Löning T
    Int J Gynecol Pathol; 2003 Apr; 22(2):168-74. PubMed ID: 12649672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.